MEK inhibition activates STAT signaling to increase breast cancer immunogenicity via MHC-I expression

por Franklin, Derek A., James, Jamaal L., Axelrod, Margaret L., Balko, Justin M.
Publicado 2020

Potent STING activation stimulates immunogenic cell death to enhance antitumor immunity in neuroblastoma

por Wang-Bishop, Lihong, Wehbe, Mohamed, Shae, Daniel, James, Jamaal, Hacker, Benjamin C., Garland, Kyle, Chistov, Plamen P., Rafat, Marjan, Balko, Justin M., Wilson, John T.
Publicado 2020

Polycomb repressor complex 2 suppresses interferon-responsive MHC-II expression in melanoma cells and is associated with anti-PD-1 resistance

por James, Jamaal L, Taylor, Brandie C, Axelrod, Margaret L, Sun, Xiaopeng, Guerin, Lindsey N, Gonzalez-Ericsson, Paula I, Wang, Yu, Sanchez, Violeta, Fahey, Catherine, Sanders, Melinda E, Xu, Yaomin, Hodges, Emily, Johnson, Douglas B, Balko, Justin M
Publicado 2023

Multi-omics analysis identifies therapeutic vulnerabilities in triple-negative breast cancer subtypes

por Lehmann, Brian D., Colaprico, Antonio, Silva, Tiago C., Chen, Jianjiao, An, Hanbing, Ban, Yuguang, Huang, Hanchen, Wang, Lily, James, Jamaal L., Balko, Justin M., Gonzalez-Ericsson, Paula I., Sanders, Melinda E., Zhang, Bing, Pietenpol, Jennifer A., Chen, X. Steven
Publicado 2021